This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...

If you’re eyeing Pfizer stock and wondering what’s next, you’re definitely not alone. The last few years have been a roller ...

Pfizer (PFE) shares have been inching upward recently, sparking some fresh attention from investors looking to understand ...

Pfizer enters the obesity drug market with a reasonably valued deal, while valuation remains attractive and technicals show ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

Pfizer Inc. is a global biopharmaceutical leader with a diversified product portfolio and significant scale, supported by ...

A judge has denied BioMed Realty’s motions to intervene in its bid to recover millions from a tenant over a breached ...

Pfizer PFE is due to report third-quarter 2025 results on Nov. 4. All eyes will be on sales of Pfizer’s oncology drugs, which ...

Baby Boomers should be looking to play things a bit more cautiously as stock valuations begin to climb across the board.

The stocks to watch this week along with all the stock market news you need to know and how to invest. FREE Report! See the ...

Dividend stocks with high yields can be great investment opportunities, but those yields can also be red flags.

According to TipRanks.com, Breen is a 3-star analyst with an average return of 7.6% and a 81.3% success rate. Breen covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck ...